A detailed history of Pathstone Family Office, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Pathstone Family Office, LLC holds 48,177 shares of LLY stock, worth $38.3 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
48,177
Previous 21,763 121.37%
Holding current value
$38.3 Million
Previous $10.2 Million 153.55%
% of portfolio
0.17%
Previous 0.15%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $11.5 Million - $15.8 Million
26,414 Added 121.37%
48,177 $25.9 Million
Q2 2023

Jan 12, 2024

SELL
$350.74 - $468.98 $9.26 Million - $12.4 Million
-26,406 Reduced 54.81%
21,771 $10.2 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $503,311 - $672,986
1,435 Added 7.06%
21,763 $10.2 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $3.71 Million - $4.36 Million
-11,949 Reduced 37.02%
20,328 $6.98 Million
Q4 2022

Oct 23, 2023

BUY
$321.55 - $374.67 $4.77 Million - $5.55 Million
14,821 Added 84.9%
32,277 $11.8 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $727,024 - $847,128
2,261 Added 7.53%
32,277 $11.8 Million
Q3 2022

Oct 23, 2023

BUY
$296.48 - $337.87 $1.01 Million - $1.15 Million
3,415 Added 24.32%
17,456 $5.64 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $1.16 Million - $1.33 Million
3,929 Added 15.06%
30,016 $9.91 Million
Q2 2022

Oct 23, 2023

SELL
$278.73 - $327.27 $2.15 Million - $2.53 Million
-7,722 Reduced 35.48%
14,041 $4.55 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $4.42 Million - $5.19 Million
15,847 Added 154.76%
26,087 $8.46 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $82,845 - $102,955
-353 Reduced 3.33%
10,240 $3.11 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $159,418 - $197,839
709 Added 7.17%
10,593 $2.93 Million
Q3 2021

Nov 16, 2021

BUY
$221.6 - $272.71 $1.18 Million - $1.45 Million
5,320 Added 116.56%
9,884 $2.28 Million
Q2 2021

Aug 31, 2021

BUY
$180.55 - $233.54 $78,900 - $102,056
437 Added 10.59%
4,564 $1.05 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $184,202 - $238,459
1,121 Added 37.29%
4,127 $772,000
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $40,181 - $53,170
308 Added 11.42%
3,006 $508,000
Q1 2020

Jun 11, 2020

BUY
$119.05 - $147.35 $321,196 - $397,550
2,698 New
2,698 $374,000
Q1 2020

May 07, 2020

SELL
$119.05 - $147.35 $320,601 - $396,813
-2,693 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $534 - $662
5 Added 0.19%
2,693 $3.54 Million
Q3 2019

Nov 13, 2019

SELL
$106.79 - $116.16 $421,820 - $458,832
-3,950 Reduced 59.51%
2,688 $301,000
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $5,317 - $6,207
-48 Reduced 0.72%
6,638 $734,000
Q1 2019

May 14, 2019

BUY
$111.31 - $131.02 $456,593 - $537,444
4,102 Added 158.75%
6,686 $868,000
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $273,645 - $306,565
2,584 New
2,584 $299,000
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $2,271 - $2,606
-30 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $74 - $87
1 Added 3.45%
30 $2,000
Q4 2017

Feb 12, 2018

BUY
$81.94 - $87.89 $2,376 - $2,548
29 New
29 $2,000
Q3 2017

Nov 14, 2017

SELL
$77.07 - $85.54 $2,235 - $2,480
-29 Closed
0 $0
Q2 2017

Aug 16, 2017

BUY
N/A
29
29 $2,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.